Microdosing performed very well on this survey. There is a recently published self-blinding citizen science placebo-controlled trial to explore benefits of psychedelic microdosing. There was essentially little to no difference from placebo: https://elifesciences.org/articles/62878
*If* we were to accept that benefits of microdosing are be…
Microdosing performed very well on this survey. There is a recently published self-blinding citizen science placebo-controlled trial to explore benefits of psychedelic microdosing. There was essentially little to no difference from placebo: https://elifesciences.org/articles/62878
*If* we were to accept that benefits of microdosing are best explained due to placebo (and I am not saying the case is settled by any means), what would that imply about the rest of the nootropics on this list?
Another possibility is that the people taking this survey are not representative of the general population, and the sorts of people who read this blog are much more responsive to psilocybin than average. Rationalist/SSC types tend to be much less neurotypical than the average person.
Microdosing performed very well on this survey. There is a recently published self-blinding citizen science placebo-controlled trial to explore benefits of psychedelic microdosing. There was essentially little to no difference from placebo: https://elifesciences.org/articles/62878
*If* we were to accept that benefits of microdosing are best explained due to placebo (and I am not saying the case is settled by any means), what would that imply about the rest of the nootropics on this list?
I agree that's concerning! I think these numbers are all (generously) a combination of reality and hype, and psilocybin gets a lot of hype.
Another possibility is that the people taking this survey are not representative of the general population, and the sorts of people who read this blog are much more responsive to psilocybin than average. Rationalist/SSC types tend to be much less neurotypical than the average person.